Don Morel

Insider profile

Currently holds positions in Kensey Nash Corp, Integra Lifesciences Holdings Corp and Catalent Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Kensey Nash Corp March 22, 2010 -
Independent Director Integra Lifesciences Holdings Corp Aug. 27, 2013 -
Independent Director Catalent Inc Nov. 2, 2015 -
Chairman of the Board West Pharmaceutical Services Inc April 24, 2015 - June 30, 2015
Chairman of the Board, Chief Executive Officer West Pharmaceutical Services Inc June 1, 2006 - April 24, 2015
Don Morel's trades of Stevanato Group SpA's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
385.19
Quantity 62,695 +43.1%
Value US$802,985
US Catalent Inc (CTLT)
Transaction date
Purchase
Price
299.31
Quantity 29,563 +18.4%
Value US$42,595
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-15
S Sale
62,695 +43.1%
385.19
US$802,985 		62,695 +43.1% 385.19 US$802,985
2019-05-16 2019-05-15
US Catalent Inc (CTLT)
B Purchase
29,563 +18.4%
299.31
US$42,595 		29,563 +18.4% 299.31 US$42,595